The CDC announced their support of the Advisory Committee on Immunization Practices’ (ACIP) recommendation of expanding the COVID-19 booster eligibility to include 12-17 year old adolescents. The new vaccine schedule includes a booster of the Pfizer-BioNTech vaccine 5 months after the 2nd dose. The committee makes this recommendation after reviewing the data of 25 million doses and have concluded that it is safe for adolescents to receive the booster dose.
Read the media statement here.